Fluvoxamine does not improve time to sustained recovery in mild COVID-19
For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a
Read moreFor patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a
Read moreEx-footballer Jermaine Pennant reveals he has ADHD, joining the likes of Olivia Attwood, Johnny Vegas and Sue Perkins – as
Read moreSource: Read Full Article
Read moreA recent study published in JAMA Network Open evaluated outcomes in mechanically ventilated patients with pneumonia due to coronavirus disease
Read moreAre striking NHS staff on brink of new £3bn pay deal? Steve Barclay ‘admits 1million medics deserve one-off cash boost…
Read moreDr Zoe says walking can reduce risk of dementia We use your sign-up to provide content in ways you’ve consented
Read moreRats and mice have been the backbone of biomedical research for decades -; including research to understand cancer and pioneer
Read moreBrain structures which could predict an individual’s predisposition to accidental awareness under anesthetic have been identified for the first time
Read moreVaccination rates for U.S. kindergarteners dropped again last year, and federal officials are starting a new campaign to try to
Read more